ciprofibrate


Also found in: Wikipedia.

ciprofibrate

An anti-cholesterol fibrate drug used to treat high blood lipid levels that fail to respond to dietary measures. The drug lowers the levels of low-density lipoproteins (LDLs). A brand name is Modalim.
References in periodicals archive ?
After this assessment, the animals continue receiving the diet rich in fructose and were randomly divided into four experimental groups (n = 8 per group) as follows: HFD (high-fructose diet + 300 [micro]L of water), HFD-S (HFD + 30 mg of simvastatin by kg of BW), HFD-C (HFD + 2 mg ciprofibrate by kg of BW), and HFD-ExCA (HFD + 200 mg of Campomanesia adamantium root aqueous extract by kg of BW).
Tranexanici, Acetylcysteine, Adenosine, Alfuzosin Hydrochloride, ambenonim chloride, Amisulpride, Atenolol, Betaxolol Hydrochloride, Calcium Polystyrene sulfonate, ciprofibrate, Dextromethorphan Hydrobromide + Dexpanthenol, Dextromethorphan Hydrobromide, Dinoprost, Drotaverine hydrochloride , Isosorbide mononitrate, Milrinone, polystyrene sulfonate Natrii, Natrii Valproas + Acidii Valproicii, Natrii Valproas, Oxybutynin hydrochloride, Phospholipidum essential, Ranitidine, Sotaloli h / chlorine.
leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate.
Mixed hyperlipidemia (increased cholesterol, LDL-C and TG): fibrates (bezafibrate, ciprofibrate, fenofibrate, and gemfibrozil).
2004) reported that PPAR-[alpha] agonists, including gemfibrozil, ciprofibrate, and fenofibrate, can increase the production of the [T.
The atherogenic role of triglycerides and small, dense low density lipoproteins: impact of ciprofibrate therapy.
Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome.
But ciprofibrate can have side effects such as muscle pain and nausea," says Rimando.
The compound worked in a similar way to the commercial drug ciprofibrate, which lowers the 'bad' form of low-density lipoprotein (LDL) cholesterol and tryglicerides, a blood fat linked to heart disease.
injection, to the PPAs, clofibrate (CLO) or the more potent ciprofibrate (CPR), did not exhibit any changes in hepatic microsomal lauric acid hydroxylase (LA-OHase) activities, although kidney microsomal [omega] and [omega]-6 products were increased significantly.
Effect of ciprofibrate on fibrinogen synthesis in vitro on hepatoma cells and in vivo in genetically obese Zucker rats.